Toll-like receptor 4 (TLR4) is the principal receptor for bacterial endotoxin recognition, and functional variants in the gene confer endotoxin-hyporesponsiveness in humans.
Introduction
The Toll-like receptor 4 (TLR4) is the principal receptor for bacterial endotoxin in mice and humans (1, 2) and plays a critical role in the innate immune response to both gram-negative pathogens and respiratory syncytial virus (3) . Through interactions with both CD14 antigen and Lipopolysaccharide (LPS) Binding Protein (LBP), endotoxin binds to membrane-bound TLR4 and initiates a complex intracellular signaling pathway, resulting in the activation of several nuclear transcription factors, including NF-κB. Significant inter-individual variability in response to endotoxin has long been recognized (4, 5) . Arbour and colleagues have recently demonstrated that common polymorphisms in the coding region of the TLR4 gene are responsible for a substantial portion of this variability (6) . Specifically, a substitution of glycine for asparginine at amino acid position 259 (D259G) results in reduction in cell surface expression of TLR4 and subsequent disruption of LPS-mediated signaling.
Furthermore, subjects heterozygous for D259G demonstrate a blunted bronchoconstrictor response to inhaled LPS, suggesting a dominant genetic effect. A second amino acid variant, a substitution of threonine for isoleucine at position 359 (T359I), which is in tight linkage disequilibrium (LD) with D259G, also demonstrated in vitro LPS-hyporesponsive effects. There is evidence that these functional variants are important determinants of health and disease, including sepsis susceptibility and atherogenesis (7, 8) . Smirnova and colleagues have resequenced the complete coding region of TLR4 in 348 individuals of diverse ethnic origin and identified 10 additional amino acid variants of extremely low frequency (9) . Although functional data regarding these rare variants is currently unavailable, this excess number of rare 4 Revised Manuscript:
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September 2002 variants suggests that weakly purifying selective forces influence variation at the TLR4 locus, further suggesting that these variants confer detrimental functional properties (9) .
Exposure to bacterial endotoxin has received considerable attention as a potential risk factor for the development of asthma and allergic disease (10) . Several groups have demonstrated that early-life exposure to endotoxin has a protective effect on the development of atopic phenotypes (11, 12) . For instance, in a study of children with a history of recurrent wheeze, house-dust endotoxin levels were significantly higher in the homes of infants that did not develop allergen sensitization, as compared to levels in the homes of those infants who did become sensitized (12) . The global incidence of asthma and atopic disease is rising, particularly among industrialized nations (13) , and it has been suggested that this phenomenon may be due in part to increased environmental cleanliness, reflecting a decline in early-life exposure to environmental endotoxin (14, 15) . In contrast, a recent prospective evaluation of household endotoxin exposure in a birth cohort of 499 infants at high risk of developing asthma demonstrated that higher household endotoxin levels were associated with an increased risk of persistent wheeze during the first year of life (16) . Household endotoxin level is also significantly associated with asthma severity among dust mite-sensitive children (17) . The role of endotoxin in the development and expression of asthma remains unclear (15, 18) , perhaps in part due to interindividual variability in endotoxin responsiveness. The relative importance of genetic variation in TLR4 in the development of asthma or atopy remains unknown.
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The purpose of this study was to evaluate the role of TLR4 as an asthmasusceptibility gene. Using DNA obtained from 90 ethnically diverse subjects, including 19 self-reported asthmatics, we resequenced the TLR4 locus and characterized the genetic variation. We subsequently evaluated the more common variants for evidence of association with a diagnosis of asthma or asthma-related phenotypes using a family-based genetic approach, in two large, independently ascertained cohorts. are included in the analysis presented here. A diagnosis of asthma was established based on methacholine hyperreactivity (PC 20 no greater than 12.5 mg/ml), and one or more of the following criteria for at least six months in the year prior to recruitment:
(1) asthma symptoms at least two times per week; (2) at least two usages per week of an inhaled bronchodilator; (3) daily asthma medication. Spirometry was performed according to American Thoracic Society (ATS) recommendations using a volumedisplacement spirometer, and airway responsiveness was assessed by methacholine challenge using the Wright nebulizer tidal breathing technique (21). Serum eosinophil counts were performed using center-specific methods. Skin-prick tests were performed for a standard panel of 10 common allergens as well as locally relevant allergens. Total serum IgE was measured using radioimmunoabsorbent assays from blood samples collected during the screening sessions of the CAMP study. little admixture, and is considered an example of a young founder population (23, 24) .
All subjects completed a general questionnaire modified from the standard respiratory questionnaire (25) , including questions concerning family history of asthma and/or atopy. For inclusion, probands were required to fulfill at least two of the following three criteria: (1) a minimum of three clinic visits for acute asthma within one year; (2) two or more asthma-related hospital admissions within one year; or (3) steroid (27) . Skin-prick tests were performed against a panel of 26 inhalant allergens, and blood was obtained for measurement of total serum IgE levels.
Molecular methods
The TLR4 genomic region targeted for SNP discovery included a 2. Sequence Detectors with the default sequencing protocol. Sequence chromatogram alignment and editing was performed using the Phred, Phrap, and Consed software programs (28, 29) . Putative SNP identification was performed using PolyPhred (30) with a quality threshold of 20. Identified SNPs were verified by manual review. Reaction products were separated on an ABI 3100 capillary electrophoresis system.
Allele determination was performed using ABI Prism Genotyper v.3.7 software.
SNP genotyping in the SLSJ cohort was performed using the TaqMan 5' exonuclease assay (32) . Major and minor allele probes were labeled with 5' FAM and 5' TET fluorophore as reporters, respectively. Probe fluorescence signal detection was performed using the ABI Prism 7700 Sequence Detector System (Applied Biosystems) per manufacturer's specifications.
Statistical Analysis
Hardy-Weinberg equilibrium was tested at each SNP locus on a contingency table of observed versus predicted genotype frequencies using a modified Markov-chain random walk algorithm (33) . Pair wise linkage disequilibrium between each pair of SNP loci was evaluated using a maximum likelihood method (34) to infer phase for dual heterozygotes, and was expressed as r 2 (35). Haplotypes were inferred from the
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sequence data using Bayesian methods (36) as implemented in the Phase package (37) , and were derived from the family genotype data using TRANSMIT (38) .
Genotype data was assessed for errors using the PEDCHECK (39) program.
Evidence of association with the binary traits asthma (proband definition) and skin prick test reactivity (defined as at least one positive skin prick test ≥ 3 mm diameter)
was evaluated using the transmission/disequilibrium test (TDT) (40) . The FBAT test 
Power calculations
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To assess whether we have a sufficient power to detect an association between a locus and the selected phenotypes, we used the approach of conditional power calculation by Lange & Laird (44) . This approach computes power based on the parental genotypes and the offspring phenotypes of a given data set.
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Results
Comparative sequence analysis
The 
Intragenic linkage disequilibrium and haplotype structure of the TLR4 locus
Hardy-Weinberg equilibrium (HWE) was confirmed for all loci in the African-American, Caucasian, and asthmatic cohorts. Among the Hispanic cohort, three loci (-495, 45982 and 46282) were not in HWE (empirical p-value = 0.02 at each locus). This distortion of HWE among Hispanics was due to the presence of one individual who was homozygous for the minor allele at all three loci, while the remaining 23
Hispanics surveyed were monomorphic for the wild-type alleles. The sequence tracings for this individual were of high quality (Phred quality scores >30), and allele calls were confirmed by manual inspection of the tracings. Given the relatively small sample size of the individual ethnic groups, the significance of this finding is unclear.
It is notable that among 94 Hispanic parents of asthmatic probands in the CAMP cohort (who were not included in our association studies due to the small number of Hispanic probands), loci 45982 and 46282 were both polymorphic and in HWE -the minor allele at both loci were observed in the heterozygous form only (minor allele frequencies of 0.048 and 0.044, respectively). These observations suggest that the three loci are polymorphic among Hispanics, with similar frequency distributions to those of the other populations in this study.
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Pair-wise linkage disequilibrium was measured by r 2 among the 12 SNPs with frequency >5% in at least one ethnic group (data not shown). Caucasian and Hispanic LD patterns were identical at all loci across TLR4. In contrast, LD patterns in the African-American cohort were quite distinct from those of both Caucasians and
Hispanics. Interestingly, no pair of loci was in significant LD among all three ethnic groups. Specifically, the two non-synonymous functional variants (D259G and T359I), which are in strong LD among Caucasians in our study and in Caucasian groups reported elsewhere (6) , are in only moderate LD in the African-American cohort.
Haplotypes were constructed using the 8 SNPs with minor allele frequencies of at least 10% in one or more populations ( Family-based association analysis of TLR4 with asthma and asthma-related phenotypes.
To investigate the hypothesis that genetic variation in TLR4 is important in the pathobiology of asthma, we genotyped five allelic variants (-6142A>G, -5749T>C, Evidence for association with the asthma phenotype was assessed using the transmission/disequilibrium test (TDT) ( To exclude the possibility of haplotype association (due either to the combined interaction of adjacent variants or to linkage disequilibrium between an untyped disease-susceptibility allele and TLR4 haplotype), we compared the estimated number of observed 5-allele haplotype transmissions to the expected number, as derived from the estimated parental haplotypes, using the TRANSMIT program (Version 2.5)(38). The 5 SNPs selected allow for 98.5% discrimination of the observed Caucasian haplotypes, with one rare haplotype (number 11 in Table 2) being indistinguishable from haplotype 1. Table 4 shows the results for the individual haplotype analysis in both the Caucasian CAMP and SLSJ families. We detected no significant association between the asthma phenotype and TLR4 haplotypes. No haplotype association was observed in either the Hispanic-American or AfricanAmerican trios (data not shown), although the genotyped loci do not accurately discriminate between the common haplotypes in the later population (Table 2 ). Of note, haplotype 2 (C and E in Table 4 ), which was observed at higher frequency among asthmatics than among Caucasians and Hispanics in the sequencing cohorts, demonstrated balanced transmission in all family-based cohorts.
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Four quantitative asthma-related traits (percent predicted post-bronchodilator FEV 1 , airway hyperresponsiveness to methacholine [log-transformed PC 20 ], total serum IgE levels, and total serum eosinophils [both log-transformed]) were assessed for evidence of association to TLR4. In the SLSJ cohort, a weak association was noted between the -6142A>G locus and serum eosinophil levels (T score = 1.31, unadjusted p-value = 0.04); there was no such finding in the CAMP cohorts. No associations were observed between the remaining phenotypes and any of the five SNPs assessed, including the functional variants conferring endotoxin hyporesponsiveness (data not shown).
Power calculations
We examined the possibility that our failure to detect an association between the TLR4 locus and asthma susceptibility was due to insufficient power using the PBAT Power Calculator (http://www.biostat.harvard.edu/~fbat/pbat.htm). We assessed the conditional power to detect the association with the functional polymorphism D259G
and both the dichotomous and continuous traits. In the CAMP Caucasian cohort (which had a minor allele frequency for the D259G variant of 5%), our sample of 480
Caucasian trios was sufficiently large to detect an association between the selected phenotypes and D259G at significance level of 5%. For disease status, we computed the conditional power of the data set for additive, dominant and recessive models.
The conditional power is at least 80% for an attributable fraction of 0.02, and at least 90% for an attributable fraction of 0.05. For the continuous phenotypes, we also 
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Discussion
This study represents the first evaluation of the TLR4 gene as an asthmasusceptibility locus. Using a large sample of both asthmatic and unaffected individuals, we identified the common genetic variation at this locus, assessed the extent of linkage disequilibrium across the gene, and characterized the common haplotype structure in several ethnically diverse populations. Using a family-based approach, we evaluated the common allelic variants for evidence of association to the asthma phenotype using two large, independently ascertained cohorts. We found no evidence to support a significant association between TLR4 polymorphisms and a diagnosis of asthma. The common -5723T variant demonstrated weak evidence for preferential transmission to asthmatic probands in the CAMP families of Caucasian origin, but not at a statistically significant level. In addition, this preferential transmission was not observed among the African American, Hispanic American or SLSJ families. Importantly, we found no evidence of significant association between endotoxin-hyporesponsiveness TLR4 variants and asthma, and found no evidence of association between asthma and the common TLR4 haplotypes. Finally, we found no evidence for association between TLR4 genetic variation and several asthma and atopy-related quantitative traits. These findings suggest that common genetic variation at the TLR4 locus, including variants conferring endotoxinhyporesponsiveness, is not an important determinant of asthma susceptibility.
The functional variants in TLR4 that predict endotoxin-hyporesponsiveness do not appear to affect asthma susceptibility, despite the suggestion by several
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epidemiologic studies that lack of exposure to endotoxin is a risk factor for the development of atopic and asthmatic phenotypes (11, 12) . remain several less common variants, including five rare non-synonymous SNPs (Q51R, L365F, E434K, Q470H, and Q884K) and variants restricted to only one ethnic group that we did not assess for association with asthma. Although it is possible that one or more of these variants may be associated with asthma susceptibility, their low minor allele frequencies preclude sufficient power in our cohorts to detect such an association. It has been suggested that association studies, including family-based association studies, are not suitable for the evaluation of loci like TLR4 with many rare coding variants, due to the increased allelic heterogeneity, and that linkagebased studies are preferable (9) . Although our study design does not allow us to exclude these rare variants as asthma-susceptibility variants, it is noteworthy that of the numerous genome-wide linkage-based surveys for asthma susceptibility loci published to date, none have demonstrated evidence for linkage to the TLR4 region of chromosome 9 (54). In addition, none of the rare amino acid variants were observed among the 19 asthmatics resequenced, suggesting that the prevalence of these alleles is very low among asthmatics. Together, these findings suggest that rare variants at the TLR4 locus are not important determinants of asthma susceptibility. Another limitation of our study is that we did not complete sequencing on all intervening intronic sequences and it is conceivable that we failed to identify important intronic variation that regulates gene expression. Finally, we do not have information regarding environmental endotoxin exposure, preventing us from examining a potentially important gene-by-environment interaction. It is certainly possible that TLR4 polymorphisms influence asthma risk in populations exposed to threshold levels of endotoxin, or that the functional variants of the TLR4 locus modify
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the endotoxin-atopy relationship in a highly complex manner, including distinct temporal and dose-dependent effects. Assessment of TLR4 genotype in additional cohorts with available longitudinal environmental endotoxin-exposure data would be useful to clarify this issue.
In conclusion, we have performed a comprehensive evaluation of the TLR4 locus, identified 29 polymorphic sites (17 novel), and characterized the haplotype structure.
These data should be useful for further evaluation of the role of the TLR4 locus in many complex disease states in which bacterial endotoxin may play a role, including sepsis-susceptibility, the organic dust syndrome, atherosclerosis, and occupational asthma. We evaluated the most common TLR4 SNPs in two large asthmatic cohorts and found no evidence to support the notion that TLR4 is an asthma-susceptibility gene. Further investigation in additional asthmatic cohorts of both this locus and other loci in the endotoxin-signaling pathway would be helpful to better define the role of endotoxin exposure in the development of asthma and allergy. variant at this position resulting from a thymine to adenine transversion (which was not observed in our sequencing cohort), suggesting that position c.1209 is triallelic. Haplotypes estimated based on SNPs with minor allele frequency of at least 10% in one population. * Bold-underlined SNPs represent those genotyped in CAMP and SLSJ cohorts, and resolve the most common Caucasian haplotypes. † n refers to number of chromosomes; within-population haplotype frequencies in parenthesis.
FOOTNOTES FOR TABLES
Haplotypes listed in descending order of frequency across the four populations.
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Haplotype F was not observed in sequencing cohort. 
